First Rounders - Nature Biotechnology

Podcast details

Technical and general information from the podcast's RSS feed.

Site

RSS

Apple

Recent rankings

Latest chart positions across Apple Podcasts and Spotify rankings.

Shared links between episodes and podcasts

Links found in episode descriptions and other podcasts that share them.

See all

https://www.nature.com/articles/s41587-019-0374-x
1 share

RSS feed quality and score

Technical evaluation of the podcast's RSS feed quality and structure.

See all

Publication history

Monthly episode publishing history over the past years.

Latest published episodes

Recent episodes with titles, durations, and descriptions.

See all

Good Bye

Wednesday, May 4, 2022 • Duration 04:28

Brady Huggett signs off.

Hosted on Acast. See acast.com/privacy for more information.

Read moreCollapse

Jay Keasling

Episode 56

Friday, April 1, 2022 • Duration 01:11:46

Jay Keasling is a professor in the College of Chemistry at the University of California at Berkeley, where he runs the Keasling lab. He’s also the CEO of the Joint BioEnergy Institute, and has been involved in several startups. His conversation with Nature Biotechnology covers growing up on the family farm in Nebraska, how Genentech led him into biotech, and the future of biofuels.

Hosted on Acast. See acast.com/privacy for more information.

Read moreCollapse

Grace Colón

Episode 48

Saturday, January 2, 2021 • Duration 01:03:39

Grace Colón is president and CEO of InCarda Therapeutics. Her conversation with Nature Biotechnology covers growing up in San Juan, Puerto Rico; her love of musical theater; and how grad school at MIT guided her toward a career in entrepreneurship.

Hosted on Acast. See acast.com/privacy for more information.

Read moreCollapse

Tillman Gerngross

Episode 47

Sunday, November 1, 2020 • Duration 01:12:00

Tillman Gerngross is the CEO and co-founder of Adimab, and a professor of bioengineering at Dartmouth College. His conversation with Nature Biotechnology covers his years at GlycoFi, the nature of problem solving in entrepreneurship, and Adimab’s paper last year challenging the work of MIT researcher Ram Sasisekharan.

Editor's note: Ram Sasisekharan has since been cleared of these charges. Please see https://www.statnews.com/2023/06/14/ram-sasisekharan-mit-vindicated-fraud-investigation/ and https://www.wsj.com/articles/mit-drug-researcher-cleared-in-research-probe-3d050624?utm_source=headtopics&utm_medium=news&utm_campaign=2023-06-15 for more information.

Noubar Afeyan

Episode 46

Tuesday, September 1, 2020 • Duration 01:07:46

Noubar Afeyan is the founder and CEO of Flagship Pioneering. His conversation with Nature Biotechnology covers his family fleeing the Lebanese Civil War when he was a boy, how a chance encounter at a scientific meeting opened his mind to entrepreneurism, and why immigrants (and entrepreneurs) benefit from having a “paranoid optimist” mindset.

Hosted on Acast. See acast.com/privacy for more information.

Read moreCollapse

Katrine Bosley

Episode 45

Wednesday, July 1, 2020 • Duration 01:08:37

Katrine Bosley is former CEO of Editas Medicines and Avila Therapeutics. She discusses growing up in Ohio, her first job in biotech (as an administrative assistant) and why her five years at CRISPR company Editas felt more like 1,000. This episode is part of Nature Biotechnology's focus issue on translating the CRISPR technology.

Hosted on Acast. See acast.com/privacy for more information.

Read moreCollapse

Ted Love

Episode 44

Monday, June 22, 2020 • Duration 01:22:22

Ted Love is the president and CEO of Global Blood Therapeutics. In his conversation with Nature Biotechnology, he discusses why his time at Haverford College was transformative, why he views Global Blood Therapeutics as a social justice company, and what might be gained from the “racial catharsis” happening in America after the police killing of George Floyd.

Hosted on Acast. See acast.com/privacy for more information.

Read moreCollapse

Alexis Borisy

Episode 43

Friday, May 1, 2020 • Duration 01:05:39

Alexis Borisy is CEO and Chairman of EQRx, and a long-time biotech builder with Third Rock Ventures. His conversation with Nature Biotechnology covers growing up as a “faculty brat” in Wisconsin, dropping out of his PhD program at Harvard and why, even as an investor, biotech cannot be all about the money.

Hosted on Acast. See acast.com/privacy for more information.

Read moreCollapse

Bonus: Jeremy Levin

Wednesday, April 22, 2020 • Duration 46:23

A conversation with Jeremy Levin, chairman of the Biotechnology Innovation Organization and CEO of Ovid Therapeutics, about industry versus government responses to covid19, the split within biotech on how to address charges of high prices, and why the biopharma industry is so disliked.

Hosted on Acast. See acast.com/privacy for more information.

Read moreCollapse

Bassil Dahiyat

Episode 42

Monday, March 2, 2020 • Duration 01:03:40

Bassil Dahiyat is co-founder, president and CEO of Xencor. His conversation with Nature Biotechnology covers his parents emigrating from Jordan, how Xencor has survived (and changed) over the past 22 years, and when it’s necessary for a CEO to speak out.

Hosted on Acast. See acast.com/privacy for more information.

Read moreCollapse

First Rounders – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Shared links between episodes and podcasts

RSS feed quality and score

Publication history

Latest published episodes

Related Shows Based on Content Similarities

Related Shows Based on Content Similarities

Apple Podcasts

Spotify

First Rounders – Details, episodes & analysis

Podcast details

Recent rankings

Apple Podcasts

Shared links between episodes and podcasts

Other3

Nature1

RSS feed quality and score

Publication history

Latest published episodes

Similar podcasts and content

Related Shows Based on Content Similarities

Related Shows Based on Content Similarities

Other3

Nature1

Apple Podcasts

Spotify